PRGN-2009

N/A

Report date: 2026/04/24 20:01:59

Base Information

Drug NamePRGN-2009
Drug Alias NamePRGN-2009 (a therapeutic gorilla adenovirus HPV vaccine containing multiple cytotoxic T cell epitopes of the viral oncoproteins HPV 16/18 E6 and E7, including T cell enhancer agonist epitopes.)PRGN-2009
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsOropharyngeal Squamous Cell Carcinoma (OPSCC)Vulvar NeoplasmsUterine Cervical Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPrecigen Inc
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer InstitutePrecigen Inc
Inactive CompaniesN/A
Active IndicationsOropharyngeal Squamous Cell Carcinoma (OPSCC)Vulvar NeoplasmsUterine Cervical Neoplasms +[7] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A